`
`AO 120 (Rev. 08/10}
`
`TRADEMARK
`
`TO:
`
`Mail Stop8
`
`:
`
`REPORTON THE
`
`Director of the U.S. Patent and Trademark Office
`P.O. Box 1456
`Alexandria, VA 22313-1450
`
`FILING OR DETERMINATION OF AN
`ACTION REGARDING A PATENT OR
`
`in Compliance with 35 U.S.C. § 290 and/or 15 U.S.C. § 1116 vou are hereby advised that a court action has been
`filedin the U.S, District Court
`for the District of Delaware on the folowing
`
`[_] Trademarks or
`ff Patents.
`( () the patent action involves 35 U.S.C. § 292.):
`
`DOCKET NO.
`
`PLAINTIFF
`
`DATE FELED
`8/16/2017
`
`U.S. DISTRICT COURT
`for the District of Delaware
`
`|DEFENDANT
`
`CEPHALON, INC. and EAGLE
`PHARMACEUTICALS, INC.
`
`| SLAYBACK PHARMA LIMITED LIABILITY COMPANY
`
`PATENT OR
`TRADEMARK NO.
`
`DATE OF PATENT
`OR TRADEMARK
`
`RADEMARK
`DATEN
`OF
`ER
`UIA
`HOLDER OF PATENT OR TRADEM:
`
`i US 8,791,270 B2
`%
`
`Ti29/2044
`
`Cephalon, Inc.
`
`OR TRADEMARK
`
`DATE INCLUDED
`
`PATENT OR
`TRADEMARK NO.
`
`DATE OF PATENT
`
`[] Cress Bil
`
`[] Other Pleading
`
`in the above-—entitled case, the following decisionhas been renderedor judgement issued:
`DECISIONJUDGEMENT
`
`[BY) DEPUTY CLERK
`
`Copy i-—Upon initiation of action, mail this copy to Director Copy 3-—U pon termination; of action, mail this capy te Director
`Copy 2---Upon filing document adding patent(s), vaail this copy to Birector Copy 4-—Case file copy
`
`